The evolution of bone-targeted therapies: introduction.
作者信息
Gnant Michael
机构信息
Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria.
出版信息
Semin Oncol. 2010 Oct;37 Suppl 2:S1. doi: 10.1053/j.seminoncol.2010.10.003.
Abstract
摘要
相似文献
1
The evolution of bone-targeted therapies: introduction.
Semin Oncol. 2010 Oct;37 Suppl 2:S1. doi: 10.1053/j.seminoncol.2010.10.003.
2
Implications of bone metastases and the benefits of bone-targeted therapy.
Semin Oncol. 2010 Oct;37 Suppl 2:S15-29. doi: 10.1053/j.seminoncol.2010.10.002.
3
The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
Eur J Cancer. 2011 Sep;47 Suppl 3:S38-47. doi: 10.1016/S0959-8049(11)70145-9.
4
[Targeted based therapies in metastatic breast cancer: future evolution].
Therapie. 2012 Nov-Dec;67(6):491-503. doi: 10.2515/therapie/2012068. Epub 2012 Dec 19.
5
Examining the metastatic niche: targeting the microenvironment.
Semin Oncol. 2010 Oct;37 Suppl 2:S2-14. doi: 10.1053/j.seminoncol.2010.10.007.
6
Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
J Clin Oncol. 2010 Aug 20;28(24):e412-4. doi: 10.1200/JCO.2009.26.1891. Epub 2010 Apr 20.
7
[A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2251-4.
8
Targeted drug delivery for breast cancer treatment.
Recent Pat Anticancer Drug Discov. 2013 May;8(2):143-53.
9
[A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP].
Gan To Kagaku Ryoho. 2009 Dec;36(13):2653-5.
10
Myeloma researchers gain genome, new targets, and new concerns.
J Natl Cancer Inst. 2011 Jul 20;103(14):1082-5. doi: 10.1093/jnci/djr275. Epub 2011 Jul 7.
Zotero 插件